Anthony Fauci Praises Study on Remdesivir’s Effectiveness v. Coronavirus
Dr. Anthony Fauci on Wednesday stated that Gilead Sciences research exhibiting potential for treating the coronavirus with Remdesivir was “good news.”
“The data shows that Remdesivir has a clear-cut significant positive effect in diminishing the time to recovery,” Fauci stated.
Fauci cautioned that the remedy was not a “knockout” for treating the virus however stated that the information confirmed “a very important proof of concept.”
“What it has proven is that a drug can block this virus,” he stated.
The preliminary outcomes of the drug trial confirmed at the very least 50% of sufferers handled with a five-day dosage of Remdesivir improved, in line with Gilead Sciences.
“So that’s something that will go with 31% improvement. Doesn’t seem like a knockout, 100%, it is a very important proof of concept,” he stated.
Fauci stated that the information reminded him of the primary time that he found a drug that labored treating HIV.
He additionally stated that the NIH had appeared on the knowledge and that it could be peer-reviewed.
“We think it’s really opening the door to the fact that we now have the capability of treating, and I can guarantee you, as more people, more companies, more investigators get involved it’s going to be better and better,” Fauci stated.